Keeping a healthy heart really matters.
What's your profile?

Preventive

Diagnostics

  • No Pathological Symptoms

    Our genes are largely responsible for what we are. They can indicate what risks we face for the development of numerous pathologies.
    With HEARTGENETICS’ tests, one could know if has inherited specific cardiovascular diseases and thus take simple preventive actions to avoid health complications before the disease appears or aggravates.
  • With Pathological Symptoms

    If one has been diagnosed with a disease condition, HEARTGENETICS tests can support a medical doctor to conduct a more personalized diagnostic and prognostic.
    With an integrated clinical surveillance is possible to control the disease sooner with adequate life style and personalized therapeutics.

Cardiovascular Genetics

LipoGene

To protect from the high levels of cholesterol and LDL

+
DNArterial®

To protect from arterial hypertension

+
TromboGene

To assess the risk of thromboembolic diseases

+
SportGene

For safe practicing of sports

+
HCMScreening

Genetic study of Hypertrophic Cardiomyopathy

+

Pharmacogenetics

Clopidogrel

Genetic Study of Clopidogrel Pharmacogenetics

+
Warfarin

Genetic Study of Warfarin
Pharmacogenetics

+
Simvastatin

Genetic Study of Simvastatin
Pharmacogenetics

+
OncoAlvo®

EGFR Target Therapy Decision in Metastatic Colon Rectal Cancer

+

Wellness

MyNutriGenes®

Your targeted nutritional plan recommendations.

+
  • LipoGene

    Genetic evaluation of
    Familial Hypercholesterolemia

    To care about the adverse
    effects of high levels of cholesterol and LDL (bad cholesterol)

    • FAMILY EXTENSIVE
      Know the predisposition for high levels of LDL
    • EVALUATES
      Estimate the condition severity and learn what consequences it can bring
    • ADEQUATE LIFESTYLE
      Learn best lifestyle to avoid high levels of LDL

     

     

    Learn more about this genetic test
  • DNArterial®

    Genetic test for High Risk and
    Prevalence for Arterial Hypertension (AHTN)

    To be aware of the genetic risk for high blood pressure

    • VIGILANT
      Evaluates the inherited risk of disease helping to prevent health problems before they appear.
    • PERSONALIZED
      Supports the medical doctor to evaluate and determine the specific cause of high blood pressure.
    • HEALTH IMPROVEMENT
      Informs about the most effective therapeutics for each individual, allowing to recover or control the disease.
  • TromboGene

    Genetic evaluation
    of Thrombophilia

    To assess the risk of thromboembolic diseases

    • HEALTH SURVEILLANCE
      Assess the risk of developing thrombovascular diseases.
    • GUIDANCE
      Guides the medical doctor about simple actions for preventing or treating thromboembolic diseases.
    • NON-INVASIVE
      Only a small sample of blood or saliva is needed to benefit from assessing the risk of thromboembolism.
    Learn more about this genetic test
  • SportGene

    Genetic pathologic markers for
    Hypertrophic Cardiomyopathy (HCM)

    For individuals who have a personal or
    familiar history of myocardial diseases.

    • PRACTICE SPORTS SAFELY
      Adequates sports practice according to myocardial clinical and genetic evaluation.
    • UNIQUE TEST
      A personalized test to inform about the risk of HCM supporting clinical evaluation.
    • PREVENTS
      Informs about precautions to take before or after pathology development.
  • HCMScreening

    Genetic Study of Hypertrophic
    Cardiomyopathy

    Combines SportGene with other genetic variants for a comprehensive evaluation of Hypertrophic Cardiomyopathy

    • SURVEILLANCE
      Advise on lifestyles and on the precautions to be taken, before and/or after HCM development.
    • EFFECTIVE
      Differentiate HCM from the non-pathogenic “athlete’s heart”.
    • FAMILY EXTENSIVE 
      May estimate genetic risk for the family relatives who inherited the genetic mutation(s).
  • Clopidogrel

    Genetic Study of Clopidogrel
    Pharmacogenetics

    As recommended by FDA and Clinical Pharmacogenetics Implementation Consortium (CPIC).

    • PERSONALISED
      Defines the Clopidogrel optimal dose therapy and/or recommends for alternative anti-platelet therapy.
    • RISK ASSESSMENT
      Defines the risk of adverse cardiovascular events and platelet aggregation.
    • CLINICALLY RELEVANT
      Distinguishes non-responsive or resistant patients.
  • Warfarin

    Genetic Study of Warfarin Pharmacogenetics

    As recommended by FDA and Clinical Pharmacogenetics Implementation Consortium (CPIC).

    • PERSONALISED
      Defines the optimal Warfarin dose therapy and/or recommends for alternative anti-platelet therapy.
    • RISK ASSESSMENT
      Minimizes the risk for bleeding and blood-clot formation.
    • CLINICALLY RELEVANT
      Reduces the time to achieve a therapeutic prothrombin time.
    Learn more about this genetic test
  • Simvastatin

    Genetic Study of Simvastatin Pharmacogenetics

    As recommended by FDA and Clinical Pharmacogenetics Implementation Consortium (CPIC).

    • PERSONALISED
      Defines the Simvastatin optimal dose therapy and/or recommends for alternative statin therapy.
    • RISK ASSESSMENT
      Defines the risk of Simvastatin-induced myopathy.
    • UPDATED
      Up-to-date genetic information.
  • OncoAlvo®

    EGFR Target Therapy Decision
    in Metastatic Colon Rectal Cancer

    Cancer is Personal.
    So is its treatment.

    • KRAS, NRAS, BRAF; among others
      More than 170 mutations.
    • COMPLETE
      Analyses all mutations from ESMO, ASCO & NICE guidelines.
    • ACTIONABLE DECISIONS
      Robust method with fast turnaround times.

    Download OncoAlvo® Flyer

  • MyNutriGenes®

    Your targeted nutritional
    plan recommendations*

    Are you eating right? Ask your genes.

    • PERSONALIZED NUTRITIONAL PLAN
      Based in your unique genetic profile.
    • 3X MORE SUCCESS
      More actionable and long lasting results.
    • COMPLETE
      Evaluation in 5 areas: Weight gain; Nutrition related to fat mass; Metabolism; Nutritional needs and detox; Appetite control.

    * The results of this genetic test cannot be used for clinical diagnostics, disease prevention or to identify a clinical condition.

    Learn more about this genetic test

Product Comparison

Hereditary Thrombophilia
Nr. Genes
Nr. Genetic
Variants
Genes (Nr Genetic Variants)
Pharmacogenetics
Product Sheet
Download
TromboGene (ref. TRB)
10
14
F13A(1), FII(2), FV(1), FBG(1), GP1BA(1), MTHFR(2), PAI1(2), PROCR(1), PROS1(1), SERPNIC1(2)
--
TromboGene + Warfarin Pharmacogenetics (ref. TRB + WRF)
12
17
CYP2C9(2), VKORC1 (1), F13A(1), FII(2), FV(1), FBG(1), GP1BA(1),
MTHFR(2), PAI1(2), PROCR(1), PROS1(1), SERPNIC1(2)
Hypertrophic Cardiomyopathy
Nr. Genes
Nr. Genetic
Variants
Genes (Nr Genetic Variants)
Pharmacogenetics
Product Sheet
Download
HCM Screening (ref. HCM)
57
963
ACTA1(1), ACTC1(14), ACTN2(4), ANKRD1(3), BRAF(1), CALM3(1), CALR3(2), CASQ2(1), CAV3(1) , COA5(1), COX15(2), CRYAB(1), CSRP3(11), DES(1), FLNC(4), FHL1(4), FHOD3(1), FXN(1), GLA(1), JPH2(4), KLF10(6), LAMP2(1), LDB3(1), MAP2K1(1), MAP2K2(1), MRPL3(1), MTO1(2), MYBPC3(373), MYH6(3), MYH7(308), MYL2(16), MYL3(12), MYLK2(2), MYO6(1), MYOM1(1), MYOZ2(2), MYPN(8), NDUFAF1(2), NDUFV2(1), NEXN(2), OBSCN(1), PDLIM3(1), PLN(7), PRKAG2(7), RAF1(1), SLC25A3(1), SLC25A4(2), SOS1(2), SRI(1), TCAP(6), TNNC1(7), TNNI3(44), TNNT2(54), TPM1(16), TRIM63(3), TTN(6), VCL(1)
--
SportGene (ref. HCM-MPM)
18
218
ACTC1(3), ACTC2(1), BRAF(1), CRYAB(1), CSRP3(2), FHL1(2), FLNC(4), LAMP2(1), LDB3(1), MYBPC3(93), MYH7(57), MYL2(1), MYL3(7), TCAP(2), TNNC1(2), TNNI3(15), TNNT2(20), TPM1(5)
--
Arterial Hypertension
Nr. Genes
Nr. Genetic
Variants
Genes (Nr Genetic Variants)
Pharmacogenetics
Product Sheet
Download
DNArterial© (ref. AHTN1)
37
57
ACE (1), ADD1 (1), ADRA1A (2), ADRB1 (2), ADRB2 (1), AGT (3), AGTR1 (2), AGTR2 (2), BDKRB2 (1), CACNB2 (1), CACNA1C (1), CALCA (1), CLCNKA (1), CLCNKB (1), CORIN (2), CYBA (2), CYP4A11 (1), CYP17A1 (1), DRD3 (1), ECE1 (1), EDN1 (1), EDNRA (1), FGF5 (1), GCH1 (1), GRK4 (3), KCNMB1 (2), NOS2 (1), NOS3 (2), NPPA (3), NPPC (1), NR3C2 (1), REN (4), RETN (1), SCNN1A (2), SLC12A3 (2), STK39 (1), WNK1 (2)
Familial Hypercholesterolemia
Nr. Genes
Nr. Genetic
Variants
Genes (Nr Genetic Variants)
Pharmacogenetics
Product Sheet
Download
LipoGene (ref. FH)
4
125
APOB(13), APOE(2), LDLR(99), PCSK9(11)
--
Familial Studies
Nr. Genes
Nr. Genetic
Variants
Genes (Nr Genetic Variants)
Pharmacogenetics
Product Sheet
Download
Familial Studies (ref.FS)
1
1
Evaluated pathologies:
Dilated Cardiomyopathy; Long and Short QT Syndromes; Brugada Syndrome; Noonan Syndrome and associated syndromes; Marfan Syndrome and associated syndromes
--
Pharmacogenetics
Nr. Genes
Nr. Genetic
Variants
Genes (Nr Genetic Variants)
Pharmacogenetics
Product Sheet
Download
Warfarin (ref. WRF)
2
3
CYP2C9(2), VKORC1 (1)
Simvastatin (ref. SVT)
1
3
SLCO1B1(3)
Clopidogrel (ref. CLP)
1
3
CYP2C19(3)

5 reasons
Why HeartGenetics

1. Experts in Genetic Medicine

We have a multidisciplinary team of PhD and specialists in Genetics, Bioinformatics and Molecular Biology focused in a more preventive, participative and predictive heart medicine. We are 100% committed to the quality of our services.

2. Innovative

At HeartGenetics, we use an award-wining innovative and highly accurate methodology to provide genetic tests tailored to each person. All our genetic tests have 99% accuracy.

3. Personalised 

Our genetic tests support the clinical evaluation concerning the causes, severity and progression of the disease, allowing personalised lifestyle changes and therapeutics.

4. Quality

We are an ISO 9001:2008 and ISO 13485:2003 certified company. We use a full-automatized management system that reduces the likelihood of both false positives and negatives.

5. Privacy

HeartGenetics ensures the privacy of all personal information and test results in accordance with the National Committee for Data Protection (N.º 8398/2013). Your medical doctor is the only person to know the test results by using our proprietary software “HeartDecode”.

 

WHS2015